Tvardi Therapeutics (TVRD) Total Current Liabilities: 2013-2017
Historic Total Current Liabilities for Tvardi Therapeutics (TVRD) over the last 4 years, with Sep 2017 value amounting to $7.3 million.
- Tvardi Therapeutics' Total Current Liabilities rose 6.55% to $7.3 million in Q3 2017 from the same period last year, while for Sep 2017 it was $7.3 million, marking a year-over-year increase of 6.55%. This contributed to the annual value of $11.5 million for FY2016, which is 118.93% up from last year.
- Latest data reveals that Tvardi Therapeutics reported Total Current Liabilities of $7.3 million as of Q3 2017, which was up 1.14% from $7.2 million recorded in Q2 2017.
- In the past 5 years, Tvardi Therapeutics' Total Current Liabilities ranged from a high of $12.5 million in Q1 2017 and a low of $3.2 million during Q2 2015.
- In the last 3 years, Tvardi Therapeutics' Total Current Liabilities had a median value of $6.8 million in 2016 and averaged $6.8 million.
- As far as peak fluctuations go, Tvardi Therapeutics' Total Current Liabilities tumbled by 44.62% in 2015, and later skyrocketed by 152.18% in 2016.
- Quarterly analysis of 5 years shows Tvardi Therapeutics' Total Current Liabilities stood at $5.4 million in 2013, then slumped by 37.46% to $3.4 million in 2014, then soared by 55.03% to $5.3 million in 2015, then soared by 118.93% to $11.5 million in 2016, then increased by 6.55% to $7.3 million in 2017.
- Its Total Current Liabilities was $7.3 million in Q3 2017, compared to $7.2 million in Q2 2017 and $12.5 million in Q1 2017.